Inmunotek S.L.
Inmunotek is a pharmaceutical laboratory based in Alcalá de Henares, Madrid, specializing in research, development, manufacturing, and marketing of products for diagnosis and treatment of diseases in allergy and immunology for humans and veterinary medicine. With a multidisciplinary team of professionals including pharmacists, doctors, biologists, chemists, and engineers, Inmunotek operates under GMP standards in well-equipped laboratories for production and quality control, and has facilities for biological raw material production. The company has been committed to offering high-quality, innovative, and competitive products since 1992, approved by the Spanish Agency of Medicines, and marketed in Spain and over 50 countries worldwide.
Industries
Nr. of Employees
medium (51-250)
Inmunotek S.L.
Products
Mucosal polybacterial therapeutic vaccine for prevention of recurrent urinary tract infections
A mucosally administered polybacterial formulation developed to reduce recurrence and positive cultures in patients with recurrent urinary tract infections; supported by clinical study data.
Mucosal polybacterial vaccine formulations for recurrent respiratory infections
Polybacterial mucosal vaccine preparations investigated for reduction of recurrent respiratory infections and modulation of mucosal immunity.
Allergen immunotherapy formulations using chemically modified extracts (polymerized allergen mixtures) for accelerated schedules
Allergen extracts chemically modified (glutaraldehyde polymerization) to produce formulations used in accelerated immunotherapy schedules (cluster protocols) with observed rapid clinical onset in provocation tests.
Nasal irrigation saline solutions and patient guidance tools
Medical device/OTC solutions and patient information for nasal irrigation to relieve nasal congestion and reduce inflammation.
Mucosal polybacterial therapeutic vaccine for prevention of recurrent urinary tract infections
A mucosally administered polybacterial formulation developed to reduce recurrence and positive cultures in patients with recurrent urinary tract infections; supported by clinical study data.
Mucosal polybacterial vaccine formulations for recurrent respiratory infections
Polybacterial mucosal vaccine preparations investigated for reduction of recurrent respiratory infections and modulation of mucosal immunity.
Allergen immunotherapy formulations using chemically modified extracts (polymerized allergen mixtures) for accelerated schedules
Allergen extracts chemically modified (glutaraldehyde polymerization) to produce formulations used in accelerated immunotherapy schedules (cluster protocols) with observed rapid clinical onset in provocation tests.
Nasal irrigation saline solutions and patient guidance tools
Medical device/OTC solutions and patient information for nasal irrigation to relieve nasal congestion and reduce inflammation.
Services
GMP contract manufacturing for allergy and immunology products
On-site formulation and manufacture of medicines and medical devices under GMP with integrated production and quality control laboratories.
R&D collaboration in immunology and vaccine development
Collaborative research and development support for vaccine and immunotherapy projects, including formulation, preclinical and translational studies.
Clinical study collaboration and publication support
Support for clinical trial execution, investigator collaboration and dissemination of results in peer-reviewed journals and scientific meetings.
GMP contract manufacturing for allergy and immunology products
On-site formulation and manufacture of medicines and medical devices under GMP with integrated production and quality control laboratories.
R&D collaboration in immunology and vaccine development
Collaborative research and development support for vaccine and immunotherapy projects, including formulation, preclinical and translational studies.
Clinical study collaboration and publication support
Support for clinical trial execution, investigator collaboration and dissemination of results in peer-reviewed journals and scientific meetings.
Expertise Areas
- Allergen immunotherapy development
- Mucosal vaccine development (polybacterial formulations)
- Biologics and biological raw material production
- GMP-compliant manufacturing and quality control
Key Technologies
- GMP pharmaceutical manufacturing
- Glutaraldehyde-mediated protein crosslinking (allergen polymerization)
- Mucosal polybacterial vaccine formulation
- Antigen conjugation (mannan conjugation)